Your Funds and Their Impact on Men Living With Cancer

Author: Movember
This World Cancer Day, we’re proud to announce the release of our latest impact report describing the key projects accelerating prostate cancer research and outcomes for men living with the disease.

The Movember Foundation supports innovative global projects from early stage basic research into prostate cancer biology through to clinical trials. With your help, we hope to make a significant contribution to reducing prostate cancer mortality and improving the quality of life of men diagnosed and living with the disease, as well as their partners, caregivers and families. 

The case studies outlined in the report demonstrate that our investment strategy in the prostate cancer research field is having a positive impact and is progressing towards achieving our vision. Of the 22 projects showcased here, 10 are already showing significant progress towards translating innovative research ideas into potentially lifesaving treatments or programs that will help men. 

Five of the projects illustrate treatment approaches being studied in men or are actually being evaluated in human clinical trials, with the potential to lead to significant new therapies. Another four project teams are preparing promising treatments for clinical trials in the next few years. 

Across the pond, the Victorian Prostate Cancer Clinical Registry has already improved clinical practice and health for men in Victoria and is now being implemented across Australia and internationally. We are confident that these initiatives will make a major contribution over the coming years in reducing variation in treatment quality, leading to a substantial improvement on a global scale in the quality of life for many men living with and beyond their disease.

Although we have made significant strides forward, the investment into prostate cancer research must continue in order for us to reach our vision. With your help, and help from the wider Movember community, the Movember Foundation will continue to invest in our priority areas. We will also continue to invest in driving the translation of research findings into clinical practice so that the men and families we serve get access to new treatments and services as quickly as possible.

Download the prostate cancer impact report.